{"id":19145,"date":"2024-04-01T14:29:13","date_gmt":"2024-04-01T17:29:13","guid":{"rendered":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/"},"modified":"2024-04-01T14:29:13","modified_gmt":"2024-04-01T17:29:13","slug":"tilia-infeccao-pulmonar-viral","status":"publish","type":"ensaio_clinico","link":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/","title":{"rendered":"TILIA \u2013 INFEC\u00c7\u00c3O PULMONAR VIRAL"},"content":{"rendered":"<p>Tozoraquimabe em participantes hospitalizados por infec\u00e7\u00e3o pulmonar viral que requerem oxig\u00eanio suplementar.<\/p>\n<p><strong>&nbsp;<\/strong><strong>Popula\u00e7\u00e3o: <\/strong>Pacientes hospitalizados com infec\u00e7\u00e3o pulmonar viral ou suspeita de etiologia viral; Hipoxemia que requer tratamento com O\u00b2 suplementar; <u>&lt;<\/u> 36 horas desde a interna\u00e7\u00e3o hospitalar; <u>&lt;<\/u> 14 dias desde o in\u00edcio dos sintomas de infec\u00e7\u00e3o viral respirat\u00f3ria<\/p>\n<p>ClinicalTrials.gov: NCT05624450<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tozoraquimabe em participantes hospitalizados por infec\u00e7\u00e3o pulmonar viral que requerem oxig\u00eanio suplementar. &nbsp;Popula\u00e7\u00e3o: Pacientes hospitalizados com infec\u00e7\u00e3o pulmonar viral ou suspeita de etiologia viral; Hipoxemia que requer tratamento com O\u00b2 suplementar; &lt; 36 horas desde a interna\u00e7\u00e3o hospitalar; &lt; 14 dias desde o in\u00edcio dos sintomas de infec\u00e7\u00e3o viral respirat\u00f3ria ClinicalTrials.gov: NCT05624450<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"class_list":["post-19145","ensaio_clinico","type-ensaio_clinico","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TILIA \u2013 INFEC\u00c7\u00c3O PULMONAR VIRAL - IDOR - Instituto D&#039;Or de Pesquisa e Ensino<\/title>\n<link rel=\"canonical\" href=\"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TILIA \u2013 INFEC\u00c7\u00c3O PULMONAR VIRAL - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta property=\"og:description\" content=\"Tozoraquimabe em participantes hospitalizados por infec\u00e7\u00e3o pulmonar viral que requerem oxig\u00eanio suplementar. &nbsp;Popula\u00e7\u00e3o: Pacientes hospitalizados com infec\u00e7\u00e3o pulmonar viral ou suspeita de etiologia viral; Hipoxemia que requer tratamento com O\u00b2 suplementar; &lt; 36 horas desde a interna\u00e7\u00e3o hospitalar; &lt; 14 dias desde o in\u00edcio dos sintomas de infec\u00e7\u00e3o viral respirat\u00f3ria ClinicalTrials.gov: NCT05624450\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/\" \/>\n<meta property=\"og:site_name\" content=\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/tilia-infeccao-pulmonar-viral\\\/\",\"url\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/tilia-infeccao-pulmonar-viral\\\/\",\"name\":\"TILIA \u2013 INFEC\u00c7\u00c3O PULMONAR VIRAL - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/#website\"},\"datePublished\":\"2024-04-01T17:29:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/tilia-infeccao-pulmonar-viral\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/tilia-infeccao-pulmonar-viral\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/tilia-infeccao-pulmonar-viral\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensaios Cl\u00ednicos\",\"item\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"TILIA \u2013 INFEC\u00c7\u00c3O PULMONAR VIRAL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/#website\",\"url\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/\",\"name\":\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TILIA \u2013 INFEC\u00c7\u00c3O PULMONAR VIRAL - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","canonical":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/","og_locale":"pt_BR","og_type":"article","og_title":"TILIA \u2013 INFEC\u00c7\u00c3O PULMONAR VIRAL - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","og_description":"Tozoraquimabe em participantes hospitalizados por infec\u00e7\u00e3o pulmonar viral que requerem oxig\u00eanio suplementar. &nbsp;Popula\u00e7\u00e3o: Pacientes hospitalizados com infec\u00e7\u00e3o pulmonar viral ou suspeita de etiologia viral; Hipoxemia que requer tratamento com O\u00b2 suplementar; &lt; 36 horas desde a interna\u00e7\u00e3o hospitalar; &lt; 14 dias desde o in\u00edcio dos sintomas de infec\u00e7\u00e3o viral respirat\u00f3ria ClinicalTrials.gov: NCT05624450","og_url":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/","og_site_name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/","url":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/","name":"TILIA \u2013 INFEC\u00c7\u00c3O PULMONAR VIRAL - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","isPartOf":{"@id":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/#website"},"datePublished":"2024-04-01T17:29:13+00:00","breadcrumb":{"@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/tilia-infeccao-pulmonar-viral\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/"},{"@type":"ListItem","position":2,"name":"Ensaios Cl\u00ednicos","item":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/"},{"@type":"ListItem","position":3,"name":"TILIA \u2013 INFEC\u00c7\u00c3O PULMONAR VIRAL"}]},{"@type":"WebSite","@id":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/#website","url":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/","name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico\/19145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico"}],"about":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/types\/ensaio_clinico"}],"wp:attachment":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/media?parent=19145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}